Capps Kathleen S. (CIK 2085127) reported 4 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2025-12-05). Recent activity: Sell ENTA (323 shares), Sell ENTA (85 shares), Sell ENTA (207 shares), Buy ENTA (3,163 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-12-05 | ENANTA PHARMACEUTICALS INC (ENTA) | Executive Director of Accounting, Controller (Principal Accounting Officer) | Sell | 323 | $4,596 |
| 2025-12-03 | ENANTA PHARMACEUTICALS INC (ENTA) | Executive Director of Accounting, Controller (Principal Accounting Officer) | Sell | 85 | $1,200 |
| 2025-12-03 | ENANTA PHARMACEUTICALS INC (ENTA) | Executive Director of Accounting, Controller (Principal Accounting Officer) | Sell | 207 | $2,890 |
| 2025-11-26 | ENANTA PHARMACEUTICALS INC (ENTA) | Executive Director of Accounting, Controller (Principal Accounting Officer) | Buy | 3,163 | $0 |
来源：SEC Form 4 申报文件 · 截至 2025-12-05